Article

CanSeer: A Method for Development and Clinical Translation of Personalized Cancer Therapeutics

2022-07-02

Abstract excerpt

<h4>ABSTRACT</h4> Computational modeling and analysis of biomolecular network models annotated with cancer patient-specific multi-omics data can enable the development of personalized therapies. Current endeavors aimed at employing in silico models towards personalized cancer therapeutics remain to be fully translated. In this work, we present “ CanSeer ” a novel multi-stage methodology for developing in silic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0dccba79-6d4b-5e34-8348-acfefe3eef97
DOI: 10.1101/2022.06.29.498138

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CanSeer: A Method for Development and Clinical Translation of Personalized Cancer TherapeuticsDOI 10.1101/2022.06.29.498138Read

GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model ValidationSemantic proximity Read

OncoRep: An n-of-1 reporting tool to support genome-guided treatment for breast cancer patients using RNA-sequencingSemantic proximity Read

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity Read

Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data.Semantic proximity Read

Clinical interpretation of integrative molecular profiles to guide precision cancer medicineSemantic proximity Read

SCLC TumorMiner: A Genomics Platform for Small Cell Lung Cancer Precision OncologySemantic proximity Read

Relationship Between Gene Expression and Drug Response in Triple-Negative Breast Cancer: Leveraging Single-Cell RNA Sequencing and Machine Learning to Identify Biomarker ProfilesSemantic proximity Read

Integrating genetic and gene expression data in network-based stratification analysis of cancersSemantic proximity Read

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast CancerSemantic proximity Read

The Oncology Research Information Exchange Network (ORIEN) – Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologySemantic proximity Read

BKDRP: A Biological Knowledge-Driven Approach for Drug Response Prediction Using Multi-Omics Data in Cancer Cell LinesSemantic proximity Read

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerSemantic proximity Read